BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-82. [PMID: 19724251 DOI: 10.1038/nrgastro.2009.149] [Cited by in Crossref: 363] [Cited by in F6Publishing: 316] [Article Influence: 27.9] [Reference Citation Analysis]
Number Citing Articles
1 Kim TY, Jeong WK, Sohn JH, Kim J, Kim MY, Kim Y. Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients. Liver Int 2015;35:2416-24. [DOI: 10.1111/liv.12846] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 7.9] [Reference Citation Analysis]
2 Schwarzer R, Ferlitsch A. Liver Biopsy-Transjugular. Clin Liver Dis (Hoboken) 2014;4:113-5. [PMID: 30992935 DOI: 10.1002/cld.434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kim NH, Lee T, Cho YK, Kim BI, Kim HJ. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization: Clinically evident portal hypertension. Journal of Gastroenterology and Hepatology 2018;33:1397-406. [DOI: 10.1111/jgh.14083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Jayakumar S, Carbonneau M, Hotte N, Befus AD, St Laurent C, Owen R, McCarthy M, Madsen K, Bailey RJ, Ma M. VSL#3® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis. Liver Int. 2013;33:1470-1477. [PMID: 23968203 DOI: 10.1111/liv.12280] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
5 Molina V, Sampson-Dávila J, Ferrer J, Fondevila C, Díaz Del Gobbo R, Calatayud D, Bruix J, García-Valdecasas JC, Fuster J. Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study. Surg Endosc 2018;32:2345-54. [PMID: 29218665 DOI: 10.1007/s00464-017-5930-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, Pinter M, Hernández-Gea V, Fritzer-Szekeres M, Steindl-Munda P, Trauner M, Peck-Radosavljevic M, García-Pagán JC, Ferenci P, Reiberger T. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy. Hepatology 2020;71:1023-36. [PMID: 31365764 DOI: 10.1002/hep.30885] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 15.7] [Reference Citation Analysis]
7 Ravaioli F, Colecchia A, Dajti E, Marasco G, Alemanni LV, Tamè M, Azzaroli F, Brillanti S, Mazzella G, Festi D. Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients. World J Hepatol 2018; 10(10): 731-742 [PMID: 30386466 DOI: 10.4254/wjh.v10.i10.731] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis. J Hepatol. 2017;66:849-859. [PMID: 27864004 DOI: 10.1016/j.jhep.2016.11.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
9 Kim T, Kim BW, Wang HJ, Lee HY, Won JH, Kim J, Hu XG, Sim J, Bang JB, Kim YB. Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests. Ann Surg 2016;264:330-8. [PMID: 26587849 DOI: 10.1097/SLA.0000000000001460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
10 Kihira S, Kagen AC, Vasudevan P, Jajamovich GH, Schiano TD, Andrle A, Babb JS, Fischman A, Taouli B. Non-invasive prediction of portal pressures using CT and MRI in chronic liver disease. Abdom Radiol 2016;41:42-9. [DOI: 10.1007/s00261-015-0614-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jansen C, Reiberger T, Huang J, Eischeid H, Schierwagen R, Mandorfer M, Anadol E, Schwabl P, Schwarze-Zander C, Warnecke-Eberz U, Strassburg CP, Rockstroh JK, Peck-Radosavljevic M, Odenthal M, Trebicka J. Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection. PLoS One 2015;10:e0116768. [PMID: 25646812 DOI: 10.1371/journal.pone.0116768] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
12 Wang T, Liang F, Li L, Zhang W, Wang G, Wang J, Zhang C, Qi X. A computational model-based study on the exchangeability of hepatic venous pressure gradients measured in multiple hepatic veins. Med Eng Phys 2020;84:28-35. [PMID: 32977920 DOI: 10.1016/j.medengphy.2020.07.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, Lawitz EJ, Rockey DC, Schall RA, Jia C, Mccolgan BJ, Mchutchison JG, Subramanian GM, Myers RP, Younossi Z, Ratziu V, Muir AJ, Afdhal NH, Goodman Z, Bosch J, Sanyal AJ. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology 2018;155:1140-53. [DOI: 10.1053/j.gastro.2018.07.006] [Cited by in Crossref: 114] [Cited by in F6Publishing: 113] [Article Influence: 28.5] [Reference Citation Analysis]
14 Rudnick SR, Conway JD, Russo MW. Current state of endohepatology: Diagnosis and treatment of portal hypertension and its complications with endoscopic ultrasound. World J Hepatol 2021; 13(8): 887-895 [PMID: 34552695 DOI: 10.4254/wjh.v13.i8.887] [Reference Citation Analysis]
15 Gharib AM, Han MAT, Meissner EG, Kleiner DE, Zhao X, McLaughlin M, Matthews L, Rizvi B, Abd-Elmoniem KZ, Sinkus R, Levy E, Koh C, Myers RP, Subramanian GM, Kottilil S, Heller T, Kovacs JA, Morse CG. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. Biomed Res Int 2017;2017:2067479. [PMID: 28480218 DOI: 10.1155/2017/2067479] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
16 Grønbaek H, Sandahl TD, Mortensen C, Vilstrup H, Møller HJ, Møller S. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. Aliment Pharmacol Ther. 2012;36:173-180. [PMID: 22591184 DOI: 10.1111/j.1365-2036.2012.05134.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 91] [Article Influence: 10.2] [Reference Citation Analysis]
17 Hernandez-Gea V, Turon F, Berzigotti A, Villanueva A. Management of small hepatocellular carcinoma in cirrhosis: Focus on portal hypertension. World J Gastroenterol 2013; 19(8): 1193-1199 [PMID: 23482437 DOI: 10.3748/wjg.v19.i8.1193] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
18 Calame P, Ronot M, Bouveresse S, Cervoni J, Vilgrain V, Delabrousse É. Predictive value of CT for first esophageal variceal bleeding in patients with cirrhosis: Value of para-umbilical vein patency. European Journal of Radiology 2017;87:45-52. [DOI: 10.1016/j.ejrad.2016.12.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
19 Vuille-Lessard É, Rodrigues SG, Berzigotti A. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:253-89. [PMID: 33838850 DOI: 10.1016/j.cld.2021.01.005] [Reference Citation Analysis]
20 Dajti E, Colecchia A, Brandi N, Golfieri R, Renzulli M. Reply to: Triple-phase CT scan for disease progression prediction in cirrhosis: A valid repurpose? Eur J Radiol 2022;146:110076. [PMID: 34883410 DOI: 10.1016/j.ejrad.2021.110076] [Reference Citation Analysis]
21 Casellas-Robert M, Lim C, Lopez-Ben S, Lladó L, Salloum C, Codina-Font J, Comas-Cufí M, Ramos E, Figueras J, Azoulay D. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study. World J Surg 2020;44:3915-22. [PMID: 32661688 DOI: 10.1007/s00268-020-05687-9] [Reference Citation Analysis]
22 Dajti E, Renzulli M, Colecchia A, Bacchi-Reggiani ML, Milandri M, Rossini B, Ravaioli F, Marasco G, Alemanni LV, Ierardi AM, Carrafiello G, Pinzani M, Azzaroli F, Mazzella G, Golfieri R, Festi D. Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients. Dig Liver Dis 2022;54:103-10. [PMID: 33414086 DOI: 10.1016/j.dld.2020.12.114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Scheiner B, Parada-Rodriguez D, Bucsics T, Schwabl P, Mandorfer M, Pfisterer N, Riedl F, Sieghart W, Ferlitsch A, Trauner M, Peck-Radosavljevic M, Reiberger T. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol 2017;52:1008-15. [PMID: 28532189 DOI: 10.1080/00365521.2017.1329456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Reverter E, Cirera I, Albillos A, Debernardi-Venon W, Abraldes JG, Llop E, Flores A, Martínez-Palli G, Blasi A, Martínez J, Turon F, García-Valdecasas JC, Berzigotti A, de Lacy AM, Fuster J, Hernández-Gea V, Bosch J, García-Pagán JC. The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery. J Hepatol 2019;71:942-50. [PMID: 31330170 DOI: 10.1016/j.jhep.2019.07.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
25 Zhao KF, Zhu J, Li F, Ao J, Jiang GJ, Shi RS. Clinical significance of splenic artery steal syndrome in patients with cirrhotic portal hypertention. Shijie Huaren Xiaohua Zazhi 2015; 23(14): 2290-2294 [DOI: 10.11569/wcjd.v23.i14.2290] [Reference Citation Analysis]
26 Pons M, Augustin S, Scheiner B, Guillaume M, Rosselli M, Rodrigues SG, Stefanescu H, Ma MM, Mandorfer M, Mergeay-Fabre M, Procopet B, Schwabl P, Ferlitsch A, Semmler G, Berzigotti A, Tsochatzis E, Bureau C, Reiberger T, Bosch J, Abraldes JG, Genescà J. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Am J Gastroenterol 2021;116:723-32. [PMID: 33982942 DOI: 10.14309/ajg.0000000000000994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Lim C, Salloum C, Chalaye J, Lahat E, Costentin CE, Osseis M, Itti E, Feray C, Azoulay D. 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study. HPB (Oxford). 2018;. [PMID: 30401520 DOI: 10.1016/j.hpb.2018.10.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
28 Sørensen M, Larsen LP, Villadsen GE, Aagaard NK, Grønbæk H, Keiding S, Vilstrup H. β-Blockers Improve Presinusoidal Portal Hypertension. Dig Dis Sci 2018;63:3153-7. [PMID: 30003386 DOI: 10.1007/s10620-018-5186-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, Cavo M, Colecchia A. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2020;11:489. [PMID: 32318059 DOI: 10.3389/fimmu.2020.00489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
30 Buob S, Johnston AN, Webster CR. Portal hypertension: pathophysiology, diagnosis, and treatment. J Vet Intern Med. 2011;25:169-186. [PMID: 21382073 DOI: 10.1111/j.1939-1676.2011.00691.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
31 Stefanescu H, Procopet B. Noninvasive assessment of portal hypertension in cirrhosis: Liver stiffness and beyond. World J Gastroenterol 2014; 20(45): 16811-16819 [PMID: 25492995 DOI: 10.3748/wjg.v20.i45.16811] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
32 Grgurevic I, Tjesic Drinkovic I, Pinzani M. Multiparametric ultrasound in liver diseases: an overview for the practising clinician. Postgrad Med J 2019;95:425-32. [PMID: 30665903 DOI: 10.1136/postgradmedj-2018-136111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
33 Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, García-Pagán JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A. 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. Liver Int 2020;40:1435-46. [PMID: 32180327 DOI: 10.1111/liv.14439] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
34 Kreisel W, Deibert P, Kupcinskas L, Sumskiene J, Appenrodt B, Roth S, Neagu M, Rössle M, Zipprich A, Caca K, Ferlitsch A, Dilger K, Mohrbacher R, Greinwald R, Sauerbruch T. The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Dig Liver Dis 2015;47:144-50. [PMID: 25483910 DOI: 10.1016/j.dld.2014.10.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
35 Lim C, Osseis M, Lahat E, Doussot A, Sotirov D, Hemery F, Lantéri-minet M, Feray C, Salloum C, Azoulay D. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study. Surg Endosc 2019;33:811-20. [DOI: 10.1007/s00464-018-6347-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
36 Procopet B, Berzigotti A. New Tools for the Noninvasive Assessment of Cirrhosis. Curr Hepatology Rep. [DOI: 10.1007/s11901-014-0210-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Koga A, Toda K, Tatsushima K, Matsuubayashi S, Tamura N, Imamura M, Kawai K. Portal hypertension in prolonged anorexia nervosa with laxative abuse: A case report of three patients. Int J Eat Disord 2019;52:211-5. [PMID: 30636007 DOI: 10.1002/eat.23007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Israelsen M, Kim M, Suvitaival T, Madsen BS, Hansen CD, Torp N, Trost K, Thiele M, Hansen T, Legido-Quigley C, Krag A; MicrobLiver Consortium. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. JHEP Rep 2021;3:100325. [PMID: 34401690 DOI: 10.1016/j.jhepr.2021.100325] [Reference Citation Analysis]
39 Abraldes JG, Sarlieve P, Tandon P. Measurement of portal pressure. Clin Liver Dis. 2014;18:779-792. [PMID: 25438283 DOI: 10.1016/j.cld.2014.07.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
40 Ma R, Hunter P, Cousins W, Ho H, Bartlett A, Safaei S. Anatomically based simulation of hepatic perfusion in the human liver. Int J Numer Meth Biomed Engng 2019;35. [DOI: 10.1002/cnm.3229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
41 Lake-Bakaar G, Ahmed M, Evenson A, Bonder A, Faintuch S, Sundaram V. Hagen-Poiseuille’s law: The link between cirrhosis, liver stiffness, portal hypertension and hepatic decompensation. World J Hepatol 2015; 7(1): 28-32 [PMID: 25624993 DOI: 10.4254/wjh.v7.i1.28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Suk KT, Kim CH, Park SH, Sung HT, Choi JY, Han KH, Hong SH, Kim DY, Yoon JH, Kim YS. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis. J Clin Gastroenterol. 2012;46:880-886. [PMID: 22810110 DOI: 10.1097/mcg.0b013e31825f2622] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
43 Müller L, Hahn F, Mähringer-Kunz A, Stoehr F, Gairing SJ, Foerster F, Weinmann A, Galle PR, Mittler J, Pinto Dos Santos D, Pitton MB, Düber C, Fehrenbach U, Auer TA, Gebauer B, Kloeckner R. Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. United European Gastroenterol J 2021. [PMID: 34918471 DOI: 10.1002/ueg2.12188] [Reference Citation Analysis]
44 Nair H, Berzigotti A, Bosch J. Emerging therapies for portal hypertension in cirrhosis. Expert Opin Emerg Drugs 2016;21:167-81. [PMID: 27148904 DOI: 10.1080/14728214.2016.1184647] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
45 Xiao N, Li XL, Zhu XD, Huang C, Shen YH, Zhou J, Fan J, Sun HC. Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction. Surg Innov 2021;:15533506211018620. [PMID: 33993786 DOI: 10.1177/15533506211018620] [Reference Citation Analysis]
46 Hori T, Ogura Y, Ogawa K, Kaido T, Segawa H, Okajima H, Kogure T, Uemoto S. How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: strategy for donor safety with a smaller-size graft and excellent recipient results. Clin Transplant. 2012;26:E324-E334. [PMID: 22686957 DOI: 10.1111/j.1399-0012.2012.01664.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
47 Tandon P, Ripoll C, Assis D, Wongcharatrawee S, Groszmann RJ, Garcia-Tsao G. The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience. Liver Int 2016;36:1160-6. [PMID: 26763558 DOI: 10.1111/liv.13065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A, Lutz H, Schoo R, Lorenzen H, Trebicka J, Appenrodt B, Schepke M, Fimmers R; German Study Group for Prophylaxis of Variceal Rebleeding. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. Gastroenterology 2015;149:660-8.e1. [PMID: 25989386 DOI: 10.1053/j.gastro.2015.05.011] [Cited by in Crossref: 123] [Cited by in F6Publishing: 92] [Article Influence: 17.6] [Reference Citation Analysis]
49 Heebøll S, Villadsen GE, Aagaard NK, Grønbæk H, Vilstrup H, Keiding S. Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience. Scand J Gastroenterol. 2013;48:969-973. [PMID: 23755897 DOI: 10.3109/00365521.2013.805811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
50 Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, Feng G, Xiong B. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-16. [PMID: 31658174 DOI: 10.1097/MEG.0000000000001586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Lim C, Salloum C, Osseis M, Lahat E, Gómez-Gavara C, Compagnon P, Luciani A, Feray C, Azoulay D. Short-term outcomes following hepatectomy for hepatocellular carcinoma within and beyond the BCLC guidelines: A prospective study. HPB (Oxford) 2018;20:222-30. [PMID: 28935451 DOI: 10.1016/j.hpb.2017.08.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
52 Porres-Aguilar M, Mukherjee D. Portopulmonary hypertension: an update. Respirology. 2015;20:235-242. [PMID: 25523363 DOI: 10.1111/resp.12455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
53 Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and treatment of hepatic fibrosis (2019). J Dig Dis 2020;21:127-38. [PMID: 32108989 DOI: 10.1111/1751-2980.12854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Shao R, Li Z, Wang J, Qi R, Liu Q, Zhang W, Mao X, Song X, Li L, Liu Y, Zhao X, Liu C, Li X, Zuo C, Wang W, Qi X. Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China. BMJ Open 2020;10:e030960. [PMID: 32580978 DOI: 10.1136/bmjopen-2019-030960] [Reference Citation Analysis]
55 Ferrusquía-acosta J, Bassegoda O, Turco L, Reverter E, Pellone M, Bianchini M, Pérez-campuzano V, Ripoll E, García-criado Á, Graupera I, García-pagán JC, Schepis F, Senzolo M, Hernández-gea V. Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. Journal of Hepatology 2021;74:811-8. [DOI: 10.1016/j.jhep.2020.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
56 Dajti E, Marasco G, Ravaioli F, Alemanni LV, Rossini B, Colecchia L, Vestito A, Festi D, Colecchia A. The role of liver and spleen elastography in advanced chronic liver disease. Minerva Gastroenterol (Torino) 2021;67:151-63. [PMID: 34027932 DOI: 10.23736/S2724-5985.20.02793-2] [Reference Citation Analysis]
57 Jansen C, Bogs C, Verlinden W, Thiele M, Möller P, Görtzen J, Lehmann J, Vanwolleghem T, Vonghia L, Praktiknjo M, Chang J, Krag A, Strassburg CP, Francque S, Trebicka J. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study. Liver Int 2017;37:396-405. [DOI: 10.1111/liv.13243] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 12.3] [Reference Citation Analysis]
58 Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-radosavljevic M; Vienna Hepatic Hemodynamic Lab. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol 2012;47:561-8. [DOI: 10.1007/s00535-011-0517-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
59 Suk KT, Kim DY, Sohn KM, Kim DJ. Biomarkers of liver fibrosis. Adv Clin Chem 2013;62:33-122. [PMID: 24772665 DOI: 10.1016/b978-0-12-800096-0.00002-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
60 Ma C, Brunt EM. Histopathologic Evaluation of Liver Biopsy for Cirrhosis. Advances in Anatomic Pathology 2012;19:220-30. [DOI: 10.1097/pap.0b013e31825c6bab] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
61 Jachs M, Reiberger T. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clin Liver Dis 2021;25:311-26. [PMID: 33838852 DOI: 10.1016/j.cld.2021.01.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Zanetto A, Shalaby S, Feltracco P, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Recent Advances in the Management of Acute Variceal Hemorrhage. J Clin Med 2021;10:3818. [PMID: 34501265 DOI: 10.3390/jcm10173818] [Reference Citation Analysis]
63 Ahmad AK, Atzori S, Maurice J, Taylor-Robinson SD, Lim AKP. Non-invasive splenic parameters of portal hypertension: Assessment and utility. World J Hepatol 2020; 12(11): 1055-1066 [PMID: 33312429 DOI: 10.4254/wjh.v12.i11.1055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Tanaka T, Hirooka M, Koizumi Y, Watanabe T, Yoshida O, Tokumoto Y, Nakamura Y, Sunago K, Yukimoto A, Abe M, Hiasa Y. Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method. PLoS One 2021;16:e0246315. [PMID: 33539456 DOI: 10.1371/journal.pone.0246315] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 De Gottardi A, Keller PF, Hadengue A, Giostra E, Spahr L. Transjugular intravascular ultrasound for the evaluation of hepatic vasculature and parenchyma in patients with chronic liver disease. BMC Res Notes 2012;5:77. [PMID: 22284050 DOI: 10.1186/1756-0500-5-77] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
66 Haj M, Rockey DC. Predictors of clinical outcomes in cirrhosis patients. Curr Opin Gastroenterol. 2018;34:266-271. [PMID: 29846263 DOI: 10.1097/mog.0000000000000450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
67 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020; 26(22): 3000-3011 [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Qi X, Zhang X, Li Z, Hui J, Xiang Y, Chen J, Zhao J, Li J, Qi FZ, Xu Y. HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma. Oncotarget 2016;7:62789-96. [PMID: 27566593 DOI: 10.18632/oncotarget.11558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
69 Bosch J, García-pagán JC. Calculating Hepatic Venous Pressure Gradient: Feel Free to Stay Free. Journal of Vascular and Interventional Radiology 2016;27:1138-9. [DOI: 10.1016/j.jvir.2016.03.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
70 Rana R, Wang S, Li J, Basnet S, Zheng L, Yang C. Diagnostic accuracy of non-invasive methods detecting clinically significant portal hypertension in liver cirrhosis: a systematic review and meta-analysis. Minerva Med 2020;111:266-80. [PMID: 31638361 DOI: 10.23736/S0026-4806.19.06143-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141-155. [PMID: 23363263 DOI: 10.1586/egh.12.83] [Cited by in Crossref: 144] [Cited by in F6Publishing: 107] [Article Influence: 16.0] [Reference Citation Analysis]
72 Macías-Rodríguez RU, Ilarraza-Lomelí H, Ruiz-Margáin A, Ponce-de-León-Rosales S, Vargas-Vorácková F, García-Flores O, Torre A, Duarte-Rojo A. Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial. Clin Transl Gastroenterol 2016;7:e180. [PMID: 27415618 DOI: 10.1038/ctg.2016.38] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
73 Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61:526-536. [PMID: 25212123 DOI: 10.1002/hep.27431] [Cited by in Crossref: 164] [Cited by in F6Publishing: 142] [Article Influence: 23.4] [Reference Citation Analysis]
74 Alvaro D, Caporaso N, Giannini EG, Iacobellis A, Morelli M, Toniutto P, Violi F; PReBRiC (Procedure-Related Bleeding Risk in Cirrhosis) group. Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia. Eur J Clin Invest 2021;51:e13508. [PMID: 33539542 DOI: 10.1111/eci.13508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Ko S. Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma (Br J Surg 2011; 98: 1752-1758). Br J Surg 2011;98:1758-9. [PMID: 22034182 DOI: 10.1002/bjs.7671] [Reference Citation Analysis]
76 Jansen C, Leeming DJ, Mandorfer M, Byrjalsen I, Schierwagen R, Schwabl P, Karsdal MA, Anadol E, Strassburg CP, Rockstroh J, Peck-Radosavljevic M, Møller S, Bendtsen F, Krag A, Reiberger T, Trebicka J. PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. PLoS One 2014;9:e108544. [PMID: 25265505 DOI: 10.1371/journal.pone.0108544] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
77 Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol 2016; 22(1): 89-102 [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
78 Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf). 2017;5:79-89. [PMID: 28533906 DOI: 10.1093/gastro/gox012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 12.4] [Reference Citation Analysis]
79 Frankova S, Lunova M, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Urbanek P, Spicak J, Jirsa M, Sperl J. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. PLoS One 2021;16:e0244934. [PMID: 33411729 DOI: 10.1371/journal.pone.0244934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Stefanescu H, Marasco G, Calès P, Fraquelli M, Rosselli M, Ganne‐carriè N, Ledinghen V, Ravaioli F, Colecchia A, Rusu C, Andreone P, Mazzella G, Festi D. A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices. Liver Int 2019;40:175-85. [DOI: 10.1111/liv.14228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
81 Suk KT, Kim HC, Namkung S, Han SH, Choi KC, Park SH, Sung HT, Kim CH, Kim SH, Ham YL. Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol. 2013;25:1170-1176. [PMID: 23603784 DOI: 10.1097/meg.0b013e3283613139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
82 Jeon SK, Lee JM, Joo I, Yoon JH, Lee DH, Han JK. Two-dimensional Shear Wave Elastography with Propagation Maps for the Assessment of Liver Fibrosis and Clinically Significant Portal Hypertension in Patients with Chronic Liver Disease: A Prospective Study. Acad Radiol 2020;27:798-806. [PMID: 31494001 DOI: 10.1016/j.acra.2019.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
83 Han H, Yang J, Zhuge Y, Zhang M, Wu M. Point Shear Wave Elastography to Evaluate and Monitor Changing Portal Venous Pressure in Patients with Decompensated Cirrhosis. Ultrasound in Medicine & Biology 2017;43:1134-40. [DOI: 10.1016/j.ultrasmedbio.2017.01.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
84 Xiaoqing Z, Na L, Lili M, Jie C, Tiancheng L, Jian W, Shiyao C. Endoscopic Cyanoacrylate Injection with Lauromacrogol for Gastric Varices: Long-Term Outcomes and Predictors in a Retrospective Cohort Study. J Laparoendosc Adv Surg Tech A 2019;29:1135-43. [PMID: 31313965 DOI: 10.1089/lap.2019.0360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
85 Andriulli A, Tripodi A, Angeli P, Senzolo M, Primignani M, Giannini EG, Riggio O, Colli A, Prati D, Sacerdoti D, Merkel C, Basili S, Ferro D, Villa E, Di Minno G, Caraceni P, Marzioni M, Mannucci PM, Violi F, Piscaglia F, Calvaruso V, De Pietri L, Falcone M, Feltracco P, Grandone E, La Mura V, Licata A, Lucidi C, Maimone S, Marietta M, Morisco F, Napoleone L, Piano S, Raparelli V, Rebulla P, Ribero D, Sartori MT, Scalera A, Schepis F, Siciliano M, Baroni GS, Tufano A, Vitale A, Zuin M. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. Digestive and Liver Disease 2016;48:455-67. [DOI: 10.1016/j.dld.2016.02.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
86 Sutton H, Dhawan A, Grammatikopoulos T. Non-invasive Markers of Portal Hypertension: Appraisal of Adult Experience and Potential Utilisation in Children. J Pediatr Gastroenterol Nutr 2018;66:559-69. [PMID: 29287004 DOI: 10.1097/MPG.0000000000001882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
87 Pillai AK, Andring B, Patel A, Trimmer C, Kalva SP. Portal hypertension: a review of portosystemic collateral pathways and endovascular interventions. Clin Radiol. 2015;70:1047-1059. [PMID: 26188844 DOI: 10.1016/j.crad.2015.06.077] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
88 Liu F, Ning Z, Liu Y, Liu D, Tian J, Luo H, An W, Huang Y, Zou J, Liu C, Liu C, Wang L, Liu Z, Qi R, Zuo C, Zhang Q, Wang J, Zhao D, Duan Y, Peng B, Qi X, Zhang Y, Yang Y, Hou J, Dong J, Li Z, Ding H, Zhang Y, Qi X. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study. EBioMedicine 2018;36:151-8. [PMID: 30268833 DOI: 10.1016/j.ebiom.2018.09.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
89 Schleiger A, Kramer P, Salzmann M, Danne F, Schubert S, Bassir C, Müller T, Tacke F, Müller H, Berger F, Photiadis J, Ovroutski S. Evaluation of Fontan failure by classifying the severity of Fontan-associated liver disease: a single-centre cross-sectional study. European Journal of Cardio-Thoracic Surgery 2021;59:341-8. [DOI: 10.1093/ejcts/ezaa310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lin JY, Zhang CH, Zheng L, Song CL, Deng WS, Zhu YM, Zheng L, Wu LZ, Sun LC, Luo M. Assessment of a biofluid mechanics-based model for calculating portal pressure in canines. BMC Vet Res 2020;16:308. [PMID: 32843036 DOI: 10.1186/s12917-020-02478-1] [Reference Citation Analysis]
91 Kimer N, Wiese S, Mo S, Møller S, Bendtsen F. Advances in the treatment of portal hypertension in cirrhosis. Expert Rev Gastroenterol Hepatol 2016;10:961-9. [PMID: 26982499 DOI: 10.1586/17474124.2016.1166952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
92 Kimer N, Pedersen JS, Busk TM, Gluud LL, Hobolth L, Krag A, Møller S, Bendtsen F; Copenhagen Rifaximin (CoRif) Study Group. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial. Hepatology 2017;65:592-603. [PMID: 27775818 DOI: 10.1002/hep.28898] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
93 Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S. Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. JGH Open 2018;2:172-7. [PMID: 30483585 DOI: 10.1002/jgh3.12063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Vilaseca M, Guixé-Muntet S, Fernández-Iglesias A, Gracia-Sancho J. Advances in therapeutic options for portal hypertension. Therap Adv Gastroenterol 2018;11:1756284818811294. [PMID: 30505350 DOI: 10.1177/1756284818811294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
95 Mandorfer M, Hernández-gea V, Reiberger T, García-pagán JC. Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring? Curr Hepatology Rep 2019;18:174-86. [DOI: 10.1007/s11901-019-00469-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
96 Bosch J. Carvedilol: the β-blocker of choice for portal hypertension. Gut. 2013;62:1529-1530. [PMID: 23355548 DOI: 10.1136/gutjnl-2012-304182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
97 Torres Rojas AM, Lorente S, Hautefeuille M, Sanchez-Cedillo A. Hierarchical Modeling of the Liver Vascular System. Front Physiol 2021;12:733165. [PMID: 34867439 DOI: 10.3389/fphys.2021.733165] [Reference Citation Analysis]
98 Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol 2020;35:278-83. [PMID: 31222830 DOI: 10.1111/jgh.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
99 Souto EO. Endoscopic Ultrasound Evaluation of Portal Pressure. Clin Liver Dis 2022;26:e1-e10. [PMID: 34802666 DOI: 10.1016/j.cld.2021.10.001] [Reference Citation Analysis]
100 Ebel NH, Carlin K, Shaffer ML, Shivaram G, Hawkins M, Lane ER, Cooper K, Lindquester WS, Gadodia G, Murray KF. Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension. J Pediatr Gastroenterol Nutr 2019;68:788-92. [PMID: 30921261 DOI: 10.1097/MPG.0000000000002327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
101 Hidaka M, Eguchi S, Hara T, Soyama A, Okada S, Hamada T, Ono S, Adachi T, Kanetaka K, Takatsuki M. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values. J Invest Surg 2020;33:118-22. [PMID: 29856668 DOI: 10.1080/08941939.2018.1476631] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, Han G, Wang M, Liu R, Lu L, Ren Z, Chen M, Zeng Z, Liang P, Liang C, Chen M, Yan F, Wang W, Ji Y, Yun J, Cai D, Chen Y, Cheng W, Cheng S, Dai C, Guo W, Hua B, Huang X, Jia W, Li Y, Li Y, Liang J, Liu T, Lv G, Mao Y, Peng T, Ren W, Shi H, Shi G, Tao K, Wang W, Wang X, Wang Z, Xiang B, Xing B, Xu J, Yang J, Yang J, Yang Y, Yang Y, Ye S, Yin Z, Zhang B, Zhang B, Zhang L, Zhang S, Zhang T, Zhao Y, Zheng H, Zhu J, Zhu K, Liu R, Shi Y, Xiao Y, Dai Z, Teng G, Cai J, Wang W, Cai X, Li Q, Shen F, Qin S, Dong J, Fan J. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer 2020;9:682-720. [PMID: 33442540 DOI: 10.1159/000509424] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
103 Fortea JI, Puente Á, Cuadrado A, Huelin P, Pellón R, González Sánchez FJ, Mayorga M, Cagigal ML, García Carrera I, Cobreros M, Crespo J, Fábrega E. Congestive Hepatopathy. Int J Mol Sci 2020;21:E9420. [PMID: 33321947 DOI: 10.3390/ijms21249420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
104 Toyoda H, Lai PB, O'Beirne J, Chong CC, Berhane S, Reeves H, Manas D, Fox RP, Yeo W, Mo F, Chan AW, Tada T, Iñarrairaegui M, Vogel A, Schweitzer N, Chan SL, Sangro B, Kumada T, Johnson PJ. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer 2016;114:744-50. [PMID: 27022825 DOI: 10.1038/bjc.2016.33] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 16.2] [Reference Citation Analysis]
105 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings 2019;94:714-26. [DOI: 10.1016/j.mayocp.2018.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 8.3] [Reference Citation Analysis]
106 Bazarbashi AN, Ryou M. Portal pressure measurement: Have we come full circle? Gastrointest Endosc 2021;93:573-6. [PMID: 33583516 DOI: 10.1016/j.gie.2020.08.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol 2019; 25(39): 5897-5917 [PMID: 31660028 DOI: 10.3748/wjg.v25.i39.5897] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
108 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
109 Suk KT, Kim DJ. Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol 2015; 7(3): 607-615 [PMID: 25848485 DOI: 10.4254/wjh.v7.i3.607] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
110 Lens S, Baiges A, Alvarado-tapias E, Llop E, Martinez J, Fortea JI, Ibáñez-samaniego L, Mariño Z, Rodríguez-tajes S, Gallego A, Bañares R, Puente Á, Albillos A, Calleja JL, Torras X, Hernández-gea V, Bosch J, Villanueva C, García-pagán JC, Forns X. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension. Journal of Hepatology 2020;73:1415-24. [DOI: 10.1016/j.jhep.2020.05.050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
111 Karsdal MA, Krarup H, Sand JM, Christensen PB, Gerstoft J, Leeming DJ, Weis N, Schaffalitzky de Muckadell OB, Krag A. Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. Aliment Pharmacol Ther. 2014;40:233-249. [PMID: 24909260 DOI: 10.1111/apt.12820] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
112 Frydrychowicz A, Roldan-Alzate A, Winslow E, Consigny D, Campo CA, Motosugi U, Johnson KM, Wieben O, Reeder SB. Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension. Eur Radiol 2017;27:5316-24. [PMID: 28656461 DOI: 10.1007/s00330-017-4862-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
113 Lake-Bakaar G, Ahmed M, Evenson A, Bonder A, Faintuch S, Sundaram V. Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law. Liver Cancer 2014;3:428-38. [PMID: 26280004 DOI: 10.1159/000343871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Lee E, Kim YJ, Goo DE, Yang SB, Kim HJ, Jang JY, Jeong SW. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices. World J Gastroenterol 2016; 22(11): 3212-3219 [PMID: 27003998 DOI: 10.3748/wjg.v22.i11.3212] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
115 Kim G, Cho YZ, Baik SK, Kim MY, Hong WK, Kwon SO. The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic review. Korean J Radiol 2015;16:314-24. [PMID: 25741193 DOI: 10.3348/kjr.2015.16.2.314] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
116 Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010;:CD002907. [PMID: 20824832 DOI: 10.1002/14651858.CD002907.pub2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
117 Lee JY, Kim TY, Jeong WK, Kim Y, Kim J, Kim KW, Kim YH, Sohn JH. Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis. Dig Dis Sci. 2014;59:2333-2343. [PMID: 24723070 DOI: 10.1007/s10620-014-3149-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
118 Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013;62:1634-1641. [PMID: 23250049 DOI: 10.1136/gutjnl-2012-304038] [Cited by in Crossref: 175] [Cited by in F6Publishing: 138] [Article Influence: 17.5] [Reference Citation Analysis]
119 Licata A, Mazzola A, Ingrassia D, Calvaruso V, Cammà C, Craxì A. Clinical implications of the hyperdynamic syndrome in cirrhosis. Eur J Intern Med. 2014;25:795-802. [PMID: 25245607 DOI: 10.1016/j.ejim.2014.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
120 Miraglia R, Luca A, Maruzzelli L, Spada M, Riva S, Caruso S, Maggiore G, Gridelli B, Bosch J. Measurement of hepatic vein pressure gradient in children with chronic liver diseases. J Hepatol. 2010;53:624-629. [PMID: 20615572 DOI: 10.1016/j.jhep.2010.04.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
121 Simbrunner B, Beer A, Wöran K, Schmitz F, Primas C, Wewalka M, Pinter M, Dolak W, Scheiner B, Puespoek A, Trauner M, Oberhuber G, Mandorfer M, Reiberger T. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wien Klin Wochenschr 2020;132:1-11. [PMID: 31912289 DOI: 10.1007/s00508-019-01593-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
122 Villanueva C, Albillos A, Genescà J, Abraldes JG, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Garcia-pagan JC, Pavel O, Bosch J. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension: Liver Failure/Cirrhosis/Portal Hypertension. Hepatology 2016;63:197-206. [DOI: 10.1002/hep.28264] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
123 Mao W, Hu Y, Lou Y, Dou J, Zou L. Immature platelet fraction values predict recovery of platelet counts following liver transplantation. Clin Res Hepatol Gastroenterol 2015;39:469-74. [PMID: 25592682 DOI: 10.1016/j.clinre.2014.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
124 Wu LF, Xiang XX, Bai DS, Jin SJ, Zhang C, Zhou BH, Qian JJ, Jiang GQ. Novel noninvasive liver fibrotic markers to predict postoperative re-bleeding after laparoscopic splenectomy and azygoportal disconnection: a 1-year prospective study. Surg Endosc 2020. [PMID: 33094827 DOI: 10.1007/s00464-020-08111-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
125 Kreisel W, Lazaro A, Trebicka J, Grosse Perdekamp M, Schmitt-Graeff A, Deibert P. Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. Int J Mol Sci 2021;22:10372. [PMID: 34638713 DOI: 10.3390/ijms221910372] [Reference Citation Analysis]
126 Chen S, Wang JJ, Wang QQ, Hu JW, Dong S, Hu LJ, Jian YC, Liu XY, Yang GM, Xiong WJ. The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis. Patient Prefer Adherence 2015;9:961-70. [PMID: 26203230 DOI: 10.2147/PPA.S84762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
127 Bai W, Al-Karaghouli M, Stach J, Sung S, Matheson GJ, Abraldes JG. Test-Retest Reliability and Consistency of HVPG and Impact on Trial Design: A Study in 289 Patients from 20 Randomized Controlled Trials. Hepatology 2021. [PMID: 34181770 DOI: 10.1002/hep.32033] [Reference Citation Analysis]
128 Ravaioli F, Colecchia A, Alemanni LV, Vestito A, Dajti E, Marasco G, Sessa M, Pession A, Bonifazi F, Festi D. Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review. Expert Rev Gastroenterol Hepatol. 2019;13:463-484. [PMID: 30895833 DOI: 10.1080/17474124.2019.1588111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
129 Karagiannakis DS, Voulgaris T, Koureta E, Chloupi E, Papatheodoridis GV, Vlachogiannakos J. Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients. Dig Dis Sci 2019;64:2653-60. [PMID: 30989464 DOI: 10.1007/s10620-019-05616-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
130 Chang FF, Du YJ. Progress in prevention and treatment of rebleeding after endoscopic band ligation for esophageal variceal bleeding. Shijie Huaren Xiaohua Zazhi 2012; 20(29): 2795-2799 [DOI: 10.11569/wcjd.v20.i29.2795] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
131 Pind ML, Bendtsen F, Kallemose T, Møller S. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis: . European Journal of Gastroenterology & Hepatology 2016;28:948-54. [DOI: 10.1097/meg.0000000000000611] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
132 Kalambokis GN, Oikonomou A, Christou L, Kolaitis NI, Tsianos EV, Christodoulou D, Baltayiannis G. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. J Hepatol 2016;65:921-8. [PMID: 27297911 DOI: 10.1016/j.jhep.2016.06.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
133 Chopra A, Cantarovich M, Bain VG. Simultaneous liver and kidney transplants: optimizing use of this double resource. Transplantation. 2011;91:1305-1309. [PMID: 21512431 DOI: 10.1097/tp.0b013e31821bad1b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
134 Liu J, Zhang H, Xia Y, Yang T, Gao Y, Li J, Wu Y, Shen F. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford). 2019;21:1-13. [PMID: 30082213 DOI: 10.1016/j.hpb.2018.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
135 Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Yokosuka O. Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics. Eur Radiol 2015;25:812-20. [PMID: 25361826 DOI: 10.1007/s00330-014-3476-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
136 Zhou Y, Zhang W, Zhang Z, Luo J, Gu J, Liu Q, Ma J, Yan Z, Chen S, Wang J. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020;32:1235-43. [PMID: 32744824 DOI: 10.1097/MEG.0000000000001686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
137 Elwan N, Salah R, Hamisa M, Shady E, Hawash N, Abd-Elsalam S. Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration - a randomized controlled trial. F1000Res 2018;7:256. [PMID: 29707200 DOI: 10.12688/f1000research.13915.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
138 Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. Journal of Hepatology 2011;55:1017-24. [DOI: 10.1016/j.jhep.2011.01.051] [Cited by in Crossref: 200] [Cited by in F6Publishing: 177] [Article Influence: 18.2] [Reference Citation Analysis]
139 Huang SY, Abdelsalam ME, Harmoush S, Ensor JE, Chetta JA, Hwang KP, Stafford RJ, Madoff DC, Avritscher R. Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis. J Magn Reson Imaging. 2014;39:590-597. [PMID: 24532376 DOI: 10.1002/jmri.24189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
140 Rodrigues SG, Montani M, Guixé-Muntet S, De Gottardi A, Berzigotti A, Bosch J. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis. Clin Gastroenterol Hepatol 2019;17:2101-2109.e1. [PMID: 30625404 DOI: 10.1016/j.cgh.2018.12.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
141 La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology. 2010;51:2108-2116. [PMID: 20512998 DOI: 10.1002/hep.23612] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
142 Hu X, Huang X, Hou J, Ding L, Su C, Meng F. Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis. Eur Radiol 2021;31:2392-404. [PMID: 32974686 DOI: 10.1007/s00330-020-07223-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Payancé A, Bissonnette J, Roux O, Elkrief L, Gault N, Francoz C, Nekachtali O, Soubrane O, Lebrec D, Valla D, Durand F, Rautou P. Lack of clinical or haemodynamic rebound after abrupt interruption of beta-blockers in patients with cirrhosis. Aliment Pharmacol Ther 2016;43:966-73. [DOI: 10.1111/apt.13577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
144 Verma V, Sarin SK, Sharma P, Kumar A. Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis. United European Gastroenterol J 2014;2:226-31. [PMID: 25360306 DOI: 10.1177/2050640614527084] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
145 Chan SS, Colecchia A, Duarte RF, Bonifazi F, Ravaioli F, Bourhis JH. Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biol Blood Marrow Transplant 2020;26:1770-9. [PMID: 32593647 DOI: 10.1016/j.bbmt.2020.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Yang SX, Zhao JM, Xu SS. Correlation of D-xylose absorption rate with portal pressure in rats with portal hypertension. Shijie Huaren Xiaohua Zazhi 2010; 18(1): 9-13 [DOI: 10.11569/wcjd.v18.i1.9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
147 Xu G, Li F, Mao Y. Portal pressure monitoring-state-of-the-art and future perspective. Ann Transl Med. 2019;7:583. [PMID: 31807564 DOI: 10.21037/atm.2019.09.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
148 Kim DW, Yoon HM, Jung AY, Lee JS, Oh SH, Kim KM, Cho YA. Diagnostic Performance of Ultrasound Elastography for Evaluating Portal Hypertension in Children: A Systematic Review and Meta-analysis. J Ultrasound Med 2019;38:747-59. [PMID: 30117178 DOI: 10.1002/jum.14764] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
149 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Yi FF, Bai ZH, Xu XB, Qi XS. Advances in research of spontaneous splenorenal shunt in patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2019; 27(24): 1502-1508 [DOI: 10.11569/wcjd.v27.i24.1502] [Reference Citation Analysis]
151 Mura VL, Tosetti G, Primignani M, Salerno F. Use of non-selective beta blockers in cirrhosis: The evidence we need before closing (or not) the window. World J Gastroenterol 2015; 21(8): 2265-2268 [PMID: 25741132 DOI: 10.3748/wjg.v21.i8.2265] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
152 Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Verset L, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. Journal of Hepatology 2013;59:344-50. [DOI: 10.1016/j.jhep.2013.03.024] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 7.8] [Reference Citation Analysis]
153 Moylan CA, Pang H, Dellinger A, Suzuki A, Garrett ME, Guy CD, Murphy SK, Ashley-Koch AE, Choi SS, Michelotti GA, Hampton DD, Chen Y, Tillmann HL, Hauser MA, Abdelmalek MF, Diehl AM. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 2014;59:471-82. [PMID: 23913408 DOI: 10.1002/hep.26661] [Cited by in Crossref: 170] [Cited by in F6Publishing: 166] [Article Influence: 18.9] [Reference Citation Analysis]
154 Elkrief L, Ronot M, Andrade F, Dioguardi Burgio M, Issoufaly T, Zappa M, Roux O, Bissonnette J, Payancé A, Lebrec D, Francoz C, Soubrane O, Valla D, Durand F, Vilgrain V, Castera L, Rautou PE. Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 2018;47:621-30. [PMID: 29322599 DOI: 10.1111/apt.14488] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
155 Silva-Junior G, Baiges A, Turon F, Torres F, Hernández-Gea V, Bosch J, García-Pagán JC. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology 2015;62:1584-92. [PMID: 26238376 DOI: 10.1002/hep.28031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
156 Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol. 2015;62:S121-S130. [PMID: 25920081 DOI: 10.1016/j.jhep.2015.01.003] [Cited by in Crossref: 112] [Cited by in F6Publishing: 92] [Article Influence: 18.7] [Reference Citation Analysis]
157 Marasco G, Dajti E, Ravaioli F, Alemanni LV, Capuano F, Gjini K, Colecchia L, Puppini G, Cusumano C, Renzulli M, Golfieri R, Festi D, Colecchia A. Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients. Hepatol Int 2020;14:850-7. [PMID: 32557193 DOI: 10.1007/s12072-020-10062-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
158 Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: Are we there yet? J Hepatol. 2020;72:774-784. [PMID: 31981725 DOI: 10.1016/j.jhep.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
159 Holster IL, Poley JW, Kuipers EJ, Tjwa ET. Controlling gastric variceal bleeding with endoscopically applied hemostatic powder (Hemospray™). J Hepatol. 2012;57:1397-1398. [PMID: 22864337 DOI: 10.1016/j.jhep.2012.07.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
160 Bochnakova T. Hepatic Venous Pressure Gradient. Clin Liver Dis (Hoboken) 2021;17:144-8. [PMID: 33868655 DOI: 10.1002/cld.1031] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Altamirano J, Fagundes C, Dominguez M, García E, Michelena J, Cárdenas A, Guevara M, Pereira G, Torres-Vigil K, Arroyo V. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2012;10:65-71.e3. [PMID: 21946124 DOI: 10.1016/j.cgh.2011.09.011] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
162 Spahr L, Goossens N, Furrer F, Dupuis M, Vijgen S, Elkrief L, Giostra E, Rubbia-Brandt L, Frossard JL. A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis. Eur J Gastroenterol Hepatol 2018;30:967-74. [PMID: 29727387 DOI: 10.1097/MEG.0000000000001148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
163 Seijo S, Reverter E, Miquel R, Berzigotti A, Abraldes JG, Bosch J, García-Pagán JC. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis. 2012;44:855-860. [PMID: 22721839 DOI: 10.1016/j.dld.2012.05.005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
164 Reverter E, Lozano JJ, Alonso C, Berzigotti A, Seijo S, Turon F, Baiges A, Martínez‐chantar ML, Mato JM, Martínez‐arranz I, La Mura V, Hernández‐gea V, Bosch J, García‐pagán JC. Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. Liver Int 2019;39:705-13. [DOI: 10.1111/liv.14042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
165 Eichholz JC, Kirstein MM, Book T, Wedemeyer H, Voigtländer T. Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis. Eur J Gastroenterol Hepatol 2021;33:1582-7. [PMID: 32925497 DOI: 10.1097/MEG.0000000000001904] [Reference Citation Analysis]
166 Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, Feng G, Yuan F, Ge Y, Xiong B. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis. Cardiovasc Intervent Radiol 2019;42:1760-70. [PMID: 31363898 DOI: 10.1007/s00270-019-02295-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
167 Stefanescu H, Rusu C, Lupsor-Platon M, Nicoara Farcau O, Fischer P, Grigoras C, Horhat A, Stancu O, Ardelean A, Tantau M, Badea R, Procopet B. Liver Stiffness Assessed by Ultrasound Shear Wave Elastography from General Electric Accurately Predicts Clinically Significant Portal Hypertension in Patients with Advanced Chronic Liver Disease. Ultraschall Med 2020;41:526-33. [PMID: 31476787 DOI: 10.1055/a-0965-0745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
168 Wu H, Yan S, Wang G, Cui S, Zhang C, Zhu Q. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis. Scand J Gastroenterol. 2015;50:1160-1169. [PMID: 25877661 DOI: 10.3109/00365521.2015.1037346] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
169 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
170 Mousa OY, Kamath PS. A History of the Assessment of Liver Performance. Clin Liver Dis (Hoboken) 2021;18:28-48. [PMID: 34745582 DOI: 10.1002/cld.1100] [Reference Citation Analysis]
171 Song J, Huang J, Huang H, Liu S, Luo Y. Performance of spleen stiffness measurement in prediction of clinical significant portal hypertension: A meta-analysis. Clin Res Hepatol Gastroenterol. 2018;42:216-226. [PMID: 29223365 DOI: 10.1016/j.clinre.2017.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
172 Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C, Keller WIY, Meyer C, Trebicka J, Attenberger U, Thomas D. Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2021;44:1240-50. [PMID: 34021379 DOI: 10.1007/s00270-021-02852-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Aguirre-Reyes DF, Sotelo JA, Arab JP, Arrese M, Tejos R, Irarrazaval P, Tejos C, Uribe SA, Andia ME. Intrahepatic portal vein blood volume estimated by non-contrast magnetic resonance imaging for the assessment of portal hypertension. Magn Reson Imaging 2015;33:970-7. [PMID: 26117696 DOI: 10.1016/j.mri.2015.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
174 Virseda-Berdices A, Brochado-Kith O, Díez C, Hontañon V, Berenguer J, González-García J, Rojo D, Fernández-Rodríguez A, Ibañez-Samaniego L, Llop-Herrera E, Olveira A, Perez-Latorre L, Barbas C, Rava M, Resino S, Jiménez-Sousa MA. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis. J Antimicrob Chemother 2021:dkab444. [PMID: 34888660 DOI: 10.1093/jac/dkab444] [Reference Citation Analysis]
175 Li X, Kang N, Qi X, Huang Y. Artificial intelligence in the diagnosis of cirrhosis and portal hypertension. J Med Ultrason (2001) 2021. [PMID: 34787742 DOI: 10.1007/s10396-021-01153-8] [Reference Citation Analysis]
176 Chen MC, Yeh PJ, Chao HC, Chen CC, Lai MW. Primary endoscopic variceal ligation reduced acute variceal bleeding events but not long-term mortality in pediatric-onset portal hypertension. J Formos Med Assoc 2021:S0929-6646(21)00494-0. [PMID: 34782196 DOI: 10.1016/j.jfma.2021.10.022] [Reference Citation Analysis]
177 Merkel C, Montagnese S. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! Eur J Intern Med 2011;22:1-4. [PMID: 21238883 DOI: 10.1016/j.ejim.2010.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
178 Berzigotti A, Albillos A, Villanueva C, Genescá J, Ardevol A, Augustín S, Calleja JL, Bañares R, García-Pagán JC, Mesonero F, Bosch J; Ciberehd SportDiet Collaborative Group. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study. Hepatology 2017;65:1293-305. [PMID: 27997989 DOI: 10.1002/hep.28992] [Cited by in Crossref: 120] [Cited by in F6Publishing: 110] [Article Influence: 24.0] [Reference Citation Analysis]
179 Golriz M, Majlesara A, Khajeh E, Mehrabi A. Reply: Hepatic Hemodynamic Changes Following Stepwise Liver Resection (Golriz et al. J Gastrointest Surg (2016) 20:587-594). J Gastrointest Surg 2016;20:2109-10. [PMID: 27604887 DOI: 10.1007/s11605-016-3261-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
180 Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, García–pagán JC, Pinzani M, Bosch J. Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis. Gastroenterology 2013;144:102-111.e1. [DOI: 10.1053/j.gastro.2012.10.001] [Cited by in Crossref: 287] [Cited by in F6Publishing: 248] [Article Influence: 31.9] [Reference Citation Analysis]
181 Wiegand J, van Bömmel F, Duarte-Rojo A, Altamirano J, Abraldes JG, Villanueva A, Berg T. Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015. J Hepatol 2016;64:1428-45. [PMID: 26902945 DOI: 10.1016/j.jhep.2016.02.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
182 Xu SH, Wu F, Guo LH, Zhang WB, Xu HX. Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis. World J Gastroenterol 2020; 26(45): 7204-7221 [PMID: 33362377 DOI: 10.3748/wjg.v26.i45.7204] [Reference Citation Analysis]
183 Meng D, Wei Y, Feng X, Kang B, Wang X, Qi J, Zhao X, Zhu Q. CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients. Front Med (Lausanne) 2021;8:745931. [PMID: 34805214 DOI: 10.3389/fmed.2021.745931] [Reference Citation Analysis]
184 Florea M, Serban T, Tirpe GR, Tirpe A, Lupsor-Platon M. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography. J Clin Med 2021;10:2575. [PMID: 34200885 DOI: 10.3390/jcm10122575] [Reference Citation Analysis]
185 Hari A, Nair HK, De Gottardi A, Baumgartner I, Dufour JF, Berzigotti A. Diagnostic hepatic haemodynamic techniques: safety and radiation exposure. Liver Int 2017;37:148-54. [PMID: 27495217 DOI: 10.1111/liv.13215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
186 Slowik V, Monroe EJ, Friedman SD, Hsu EK, Horslen S. Pressure gradients, laboratory changes, and outcomes with transjugular intrahepatic portosystemic shunts in pediatric portal hypertension. Pediatr Transplant 2019;23:e13387. [PMID: 30932316 DOI: 10.1111/petr.13387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Bastard C, Miette V, Calès P, Stefanescu H, Festi D, Sandrin L. A Novel FibroScan Examination Dedicated to Spleen Stiffness Measurement. Ultrasound Med Biol 2018;44:1616-26. [PMID: 29731186 DOI: 10.1016/j.ultrasmedbio.2018.03.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
188 Qiu G, Jin Z, Chen X, Huang J. Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China. Glob Health Med. 2020;2:306-311. [PMID: 33330825 DOI: 10.35772/ghm.2020.01051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
189 Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6-14. [PMID: 24757653 DOI: 10.3350/cmh.2014. 20.1.6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2019;393:1597-608. [PMID: 30910320 DOI: 10.1016/S0140-6736(18)31875-0] [Cited by in Crossref: 105] [Cited by in F6Publishing: 27] [Article Influence: 35.0] [Reference Citation Analysis]
191 Kirnake V, Arora A, Sharma P, Goyal M, Chawlani R, Toshniwal J, Kumar A. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis. Indian J Gastroenterol 2018;37:335-41. [DOI: 10.1007/s12664-018-0879-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
192 Hobeika C, Cauchy F, Sartoris R, Beaufrère A, Yoh T, Vilgrain V, Rautou PE, Paradis V, Bouattour M, Ronot M, Soubrane O. Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma. Br J Surg 2020;107:878-88. [PMID: 32118298 DOI: 10.1002/bjs.11511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
193 Vincent JK, Stark C, Shields JT, Bhave AD, Morris CS. Hepatic venous pressure gradient correlates with advanced hepatic fibrosis: a retrospective review. Abdom Radiol (NY) 2017;42:2609-14. [PMID: 28474176 DOI: 10.1007/s00261-017-1171-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
194 Yoon HM, Kim SY, Kim KM, Oh SH, Ko GY, Park Y, Lee JS, Jung AY, Cho YA. Liver Stiffness Measured by Shear-wave Elastography for Evaluating Intrahepatic Portal Hypertension in Children. J Pediatr Gastroenterol Nutr 2017;64:892-7. [PMID: 28107286 DOI: 10.1097/MPG.0000000000001517] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
195 Reverter E, Blasi A, Abraldes JG, Martínez-Palli G, Seijo S, Turon F, Berzigotti A, Balust J, Bosch J, García-Pagán JC. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int 2014;34:16-25. [PMID: 23763484 DOI: 10.1111/liv.12229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
196 Li X, Zhu X, Xiao N, Liu X, Xu B, Shi G, Huang C, Shen Y, Cai J, Zhou J, Fan J, Sun H. A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study. Surgery 2020;167:926-32. [DOI: 10.1016/j.surg.2020.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67:399-411. [PMID: 28223101 DOI: 10.1016/j.jhep.2017.02.003] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 22.0] [Reference Citation Analysis]
198 González A, Augustin S, Dot J, Pérez M, Abu-Suboh M, Romero A, Segarra A, Armengol JR, Esteban R, Guardia J. Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy. Dig Liver Dis. 2012;44:55-60. [PMID: 21890439 DOI: 10.1016/j.dld.2011.07.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
199 Monroe EJ, Michalsky WS, Koo KSH, Shivaram GM, Hage AN, Hsu EK, Horslen SP, Chick JFB. Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children. Pediatr Radiol 2020;50:1579-86. [PMID: 32583092 DOI: 10.1007/s00247-020-04751-9] [Reference Citation Analysis]
200 Wang T, Liang F, Zhou Z, Qi X. Global sensitivity analysis of hepatic venous pressure gradient (HVPG) measurement with a stochastic computational model of the hepatic circulation. Computers in Biology and Medicine 2018;97:124-36. [DOI: 10.1016/j.compbiomed.2018.04.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
201 Casu S, Berzigotti A, Abraldes JG, Baringo MA, Rocabert L, Hernández-Gea V, García-Pagán JC, Bosch J. A prospective observational study on tolerance and satisfaction to hepatic haemodynamic procedures. Liver Int 2015;35:695-703. [PMID: 24628960 DOI: 10.1111/liv.12522] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
202 Wong GLH. Transient elastography: Kill two birds with one stone? World J Hepatol 2013; 5(5): 264-274 [PMID: 23717737 DOI: 10.4254/wjh.v5.i5.264] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 6.6] [Reference Citation Analysis]
203 Price A, Schwertner A, Tran D, Kohi M, Pallav Kolli K, Taylor A, Fidelman N. Outcomes of transjugular liver biopsies for liver transplant recipients with bicaval and piggyback hepatic vein anastomoses. Acta Radiol 2021;62:1537-47. [PMID: 33167667 DOI: 10.1177/0284185120969953] [Reference Citation Analysis]
204 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
205 Pelegrina A, Martí J, Miquel R, Ferrer J, Hernández-Gea V, Diaz A, Nadal C, García-Valdecasas JC, Fuster J. Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: "a note of caution". World J Surg Oncol 2017;15:224. [PMID: 29246174 DOI: 10.1186/s12957-017-1290-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
206 Zardi EM, Di Matteo FM, Pacella CM, Sanyal AJ. Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review. Ann Med. 2014;46:8-17. [PMID: 24328372 DOI: 10.3109/07853890.2013.857831] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
207 Mehta G, Gustot T, Mookerjee RP, Garcia-Pagan JC, Fallon MB, Shah VH, Moreau R, Jalan R. Inflammation and portal hypertension - the undiscovered country. J Hepatol. 2014;61:155-163. [PMID: 24657399 DOI: 10.1016/j.jhep.2014.03.014] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
208 Thiele M, Kjaergaard M, Thielsen P, Krag A. Contemporary use of elastography in liver fibrosis and portal hypertension. Clin Physiol Funct Imaging. 2017;37:235-242. [PMID: 26459184 DOI: 10.1111/cpf.12297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
209 Berzigotti A. Transient elastography and prognosis of cirrhosis. Hepatology 2012;55:1629-31. [PMID: 22517548 DOI: 10.1002/hep.25620] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
210 Shen Y, Ma W, Hang Y, Liu LL, Jiang W, Wu SD. Clinical application of liver stiffness measurement in patients with cavernous transformation of portal vein. Exp Ther Med 2021;21:442. [PMID: 33777190 DOI: 10.3892/etm.2021.9881] [Reference Citation Analysis]
211 Abraldes JG, Araujo IK, Turón F, Berzigotti A. Diagnosing and monitoring cirrhosis: Liver biopsy, hepatic venous pressure gradient and elastography. Gastroenterol Hepatol. 2012;35:488-495. [PMID: 22560536 DOI: 10.1016/j.gastrohep.2012.02.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
212 Bandali MF, Mirakhur A, Lee EW, Ferris MC, Sadler DJ, Gray RR, Wong JK. Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy. World J Gastroenterol 2017; 23(10): 1735-1746 [PMID: 28348478 DOI: 10.3748/wjg.v23.i10.1735] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
213 Etzion O, Takyar V, Novack V, Gharib AM, Canales R, Adebogun A, Matsumoto E, Eccleston JL, Kleiner DE, Rosenzweig SD, Gunay-Aygun M, Uzel G, Fuss I, Childs R, Holland SM, Levy EB, Liang TJ, Heller T, Koh C. Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal Hypertension. Hepatol Commun 2018;2:919-28. [PMID: 30094403 DOI: 10.1002/hep4.1198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
214 Bassegoda O, Olivas P, Turco L, Mandorfer M, Serra-Burriel M, Tellez L, Kwanten W, Laroyenne A, Farcau O, Alvarado E, Moga L, Vuille-Lessard E, Fortea JI, Ibañez L, Tosetti G, Vanwolleghem T, Larrue H, Burgos-Santamaría D, Stefanescu H, Paternostro R, Cippitelli A, Lens S, Augustin S, Llop E, Laleman W, Trebicka J, Chang J, Masnou H, Zipprich A, Miceli F, Semmler G, Forns X, Primignani M, Bañares R, Puente A, Berzigotti A, Rautou PE, Villanueva C, Ginès P, Garcia-Pagan JC, Procopet B, Bureau C, Albillos A, Francque S, Reiberger T, Schepis F, Graupera I, Hernandez-Gea V. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01136-8. [PMID: 34688952 DOI: 10.1016/j.cgh.2021.10.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Frangakis C, Sohn JH, Bas A, Chapiro J, Schernthaner RE, Lin M, Hamilton JP, Pawlik TM, Hong K, Duran R. Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure. Front Oncol 2021;11:639235. [PMID: 34804911 DOI: 10.3389/fonc.2021.639235] [Reference Citation Analysis]
216 Berardi S, Berzigotti A, Cappelli A, Mastroroberto M, Serra C, D'Errico A, Russo V, Garcia-Criado A, Sama C. Routine blood tests? Helping you live(r) longer! Lancet 2011;378:2048. [PMID: 22153201 DOI: 10.1016/S0140-6736(11)61456-6] [Reference Citation Analysis]
217 Dajti E, Ravaioli F, Colecchia A, Marasco G, Vestito A, Festi D. Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome. Can J Gastroenterol Hepatol 2019;2019:1673197. [PMID: 30719429 DOI: 10.1155/2019/1673197] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
218 Sanyal AJ, Harrison SA, Ratziu V, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Aguilar Schall R, Jia C, McColgan B, Djedjos CS, McHutchison JG, Subramanian GM, Myers RP, Younossi Z, Muir AJ, Afdhal NH, Bosch J, Goodman Z. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials. Hepatology. 2019;70:1913-1927. [PMID: 30993748 DOI: 10.1002/hep.30664] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 25.0] [Reference Citation Analysis]
219 Tseng Y, Ma L, Li S, Luo T, Luo J, Zhang W, Wang J, Chen S. Application of CT-based radiomics in predicting portal pressure and patient outcome in portal hypertension. Eur J Radiol 2020;126:108927. [PMID: 32146345 DOI: 10.1016/j.ejrad.2020.108927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
220 Song J, Ma Z, Huang J, Liu S, Luo Y, Lu Q, Schwabl P, Zykus R, Kumar A, Kitson M. Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis. Eur Radiol 2018;28:5221-30. [PMID: 29858640 DOI: 10.1007/s00330-018-5478-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
221 Khan F, Tripathi D. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions. World J Gastroenterol 2021; 27(44): 7612-7624 [PMID: 34908802 DOI: 10.3748/wjg.v27.i44.7612] [Reference Citation Analysis]
222 Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol 2018;3:708-19. [PMID: 30215362 DOI: 10.1016/S2468-1253(18)30232-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 11.7] [Reference Citation Analysis]
223 Wang T, Liang F, Zhou Z, Shi L. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis. J Biomech 2017;65:23-31. [PMID: 29042056 DOI: 10.1016/j.jbiomech.2017.09.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
224 Trebicka J, Reiberger T, Laleman W. Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure. Visc Med. 2018;34:270-275. [PMID: 30345284 DOI: 10.1159/000490262] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
225 Juanola O, Ferrusquía-Acosta J, García-Villalba R, Zapater P, Magaz M, Marín A, Olivas P, Baiges A, Bellot P, Turon F, Hernández-Gea V, González-Navajas JM, Tomás-Barberán FA, García-Pagán JC, Francés R. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis. FASEB J 2019;33:11595-605. [PMID: 31345057 DOI: 10.1096/fj.201901327R] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
226 Jindal A, Bhardwaj A, Kumar G, Sarin SK. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg. Am J Gastroenterol 2020;115:1624-33. [PMID: 32453061 DOI: 10.14309/ajg.0000000000000653] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
227 Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, Zheng MH. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33:62-71. [PMID: 22973991 DOI: 10.1111/liv.12003] [Cited by in Crossref: 132] [Cited by in F6Publishing: 111] [Article Influence: 13.2] [Reference Citation Analysis]
228 Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. British Journal of Surgery 2011;98:1188-200. [DOI: 10.1002/bjs.7630] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 10.5] [Reference Citation Analysis]
229 Bosch J. Small diameter shunts should lead to safe expansion of the use of TIPS. Journal of Hepatology 2021;74:230-4. [DOI: 10.1016/j.jhep.2020.09.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
230 Procopet B, Berzigotti A, Abraldes JG, Turon F, Hernandez-gea V, García-pagán JC, Bosch J. Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension. Journal of Hepatology 2015;62:1068-75. [DOI: 10.1016/j.jhep.2014.12.007] [Cited by in Crossref: 130] [Cited by in F6Publishing: 106] [Article Influence: 18.6] [Reference Citation Analysis]
231 Tseng Y, Li F, Wang J, Chen S, Jiang W, Shen X, Wu S. Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices. J Clin Ultrasound. 2018;46:442-449. [PMID: 30132919 DOI: 10.1002/jcu.22635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
232 Zhu Q, Wang W, Zhao J, Al-asbahi AAM, Huang Y, Du F, Zhou J, Song Y, Xu K, Ye J, Yang L. Transient Elastography Identifies the Risk of Esophageal Varices and Bleeding in Patients With Hepatitis B Virus–Related Liver Cirrhosis. Ultrasound Quarterly 2018;34:141-7. [DOI: 10.1097/ruq.0000000000000373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Berzigotti A, Reverter E, García-Criado A, Abraldes JG, Cerini F, García-Pagán JC, Bosch J. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension. J Hepatol. 2013;59:717-722. [PMID: 23669282 DOI: 10.1016/j.jhep.2013.04.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
234 Ferlitsch A, Bota S, Paternostro R, Reiberger T, Mandorfer M, Heinisch B, Salzl P, Schwarzer R, Sieghart W, Peck-Radosavljevic M, Ferlitsch M. Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient. Liver Int. 2015;35:2115-2120. [PMID: 25585656 DOI: 10.1111/liv.12783] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
235 Lunova M, Frankova S, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Sticova E, Spicak J, Jirsa M, Sperl J. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis. Physiol Res 2021;70:563-77. [PMID: 34062072 DOI: 10.33549/physiolres.934626] [Reference Citation Analysis]
236 Fierbinteanu-Braticevici C, Tribus L, Peagu R, Petrisor A, Baicus C, Cretoiu D, Pasternak A, Oprea G, Purcareanu A, Moldoveanu AC. Spleen Stiffness as Predictor of Esophageal Varices in Cirrhosis of Different Etiologies. Sci Rep. 2019;9:16190. [PMID: 31700031 DOI: 10.1038/s41598-019-52407-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
237 Pons M, Simón-talero M, Millán L, Ventura-cots M, Santos B, Augustin S, Genescà J. Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease. Digestive and Liver Disease 2016;48:1214-9. [DOI: 10.1016/j.dld.2016.06.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
238 La Mura V, Garcia‐guix M, Berzigotti A, Abraldes JG, García‐pagán JC, Villanueva C, Bosch J. A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding. Hepatology 2020;72:1353-65. [DOI: 10.1002/hep.31125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
239 Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, Choi JY, Han KH, Sung HT, Hong SH. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. Clin Biochem. 2012;45:1075-1080. [PMID: 22579966 DOI: 10.1016/j.clinbiochem.2012.04.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
240 Sartoris R, Rautou PE, Elkrief L, Pollorsi G, Durand F, Valla D, Spahr L, Terraz S, Soubrane O, Cauchy F, Vilgrain V, Ronot M. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology 2018;289:698-707. [PMID: 30179109 DOI: 10.1148/radiol.2018181131] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
241 Téllez L, Rodríguez de Santiago E, Albillos A. Fontan-associated Liver Disease. Rev Esp Cardiol (Engl Ed) 2018;71:192-202. [PMID: 29433942 DOI: 10.1016/j.rec.2017.10.052] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
242 Lim R, Hodge A, Moore G, Wallace EM, Sievert W. A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis. Front Pharmacol 2017;8:549. [PMID: 28878671 DOI: 10.3389/fphar.2017.00549] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
243 Semmler G, Reiberger T. Letter to Lavian and colleagues. Eur J Radiol 2021;134:109449. [PMID: 33309458 DOI: 10.1016/j.ejrad.2020.109449] [Reference Citation Analysis]
244 Schaffner D, von Elverfeldt D, Deibert P, Lazaro A, Merfort I, Lutz L, Neubauer J, Baumstark MW, Kreisel W, Reichardt W. Phase-contrast MR flow imaging: A tool to determine hepatic hemodynamics in rats with a healthy, fibrotic, or cirrhotic liver. J Magn Reson Imaging 2017;46:1526-34. [PMID: 28240794 DOI: 10.1002/jmri.25677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
245 Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience. Wien Klin Wochenschr. 2012;124:395-402. [PMID: 22699260 DOI: 10.1007/s00508-012-0190-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
246 Margini C, Murgia G, Stirnimann G, De Gottardi A, Semmo N, Casu S, Bosch J, Dufour JF, Berzigotti A. Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease. Hepatol Commun 2018;2:929-40. [PMID: 30094404 DOI: 10.1002/hep4.1201] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
247 Rodrigues SG, Brabandt B, Stirnimann G, Maurer MH, Berzigotti A. Adipopenia correlates with higher portal pressure in patients with cirrhosis. Liver Int. 2019;39:1672-1681. [PMID: 31207018 DOI: 10.1111/liv.14175] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
248 Dajti E, Alemanni LV, Marasco G, Montagnani M, Azzaroli F. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? Hepat Med 2021;13:25-36. [PMID: 33776492 DOI: 10.2147/HMER.S278077] [Reference Citation Analysis]
249 Maruyama H, Shiina S. Collaterals in portal hypertension: anatomy and clinical relevance. Quant Imaging Med Surg 2021;11:3867-81. [PMID: 34341755 DOI: 10.21037/qims-20-1328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Potthoff A, Schettler A, Attia D, Schlue J, Schmitto JD, Fegbeutel C, Strüber M, Haverich A, Manns MP, Wedemeyer H, Gebel M, Schneider A. Liver stiffness measurements and short-term survival after left ventricular assist device implantation: A pilot study. J Heart Lung Transplant 2015;34:1586-94. [PMID: 26169664 DOI: 10.1016/j.healun.2015.05.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
251 Schwabl P, Bota S, Salzl P, Mandorfer M, Payer BA, Ferlitsch A, Stift J, Wrba F, Trauner M, Peck-Radosavljevic M, Reiberger T. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int. 2015;35:381-390. [PMID: 24953516 DOI: 10.1111/liv.12623] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 10.5] [Reference Citation Analysis]
252 Leung JC, Loong TC, Pang J, Wei JL, Wong VW. Invasive and non-invasive assessment of portal hypertension. Hepatol Int 2018;12:44-55. [PMID: 28361299 DOI: 10.1007/s12072-017-9795-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
253 Maluf DG, Archer KJ, Villamil F, Stravitz RT, Mas V. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression. Expert Review of Gastroenterology & Hepatology 2014;4:445-58. [DOI: 10.1586/egh.10.39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
254 Guo H, Zhang F, Yin X, Zhang M, Xiao J, Wang Y, Zhang B, Zhang W, Zou X, Zhuge Y. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg. Eur J Gastroenterol Hepatol 2021;33:1427-35. [PMID: 32868650 DOI: 10.1097/MEG.0000000000001872] [Reference Citation Analysis]
255 Woolfson J, John P, Kamath B, Ng VL, Ling SC. Measurement of hepatic venous pressure gradient is feasible and safe in children. J Pediatr Gastroenterol Nutr. 2013;57:634-637. [PMID: 23799453 DOI: 10.1097/mpg.0b013e3182a0e114] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
256 Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, William P, Brol MJ, Turco L, Schierwagen R, Chang J, Klein S, Uschner FE, Welsch C, Moreau R, Schepis F, Bendtsen F, Gluud LL, Møller S, Trebicka J. Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure. Liver Int 2020;40:1457-66. [PMID: 32162397 DOI: 10.1111/liv.14433] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
257 Suh CH, Kim KW, Park SH, Lee SS, Kim HS, Tirumani SH, Lee JG, Pyo J. Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018;210:W185-W195. [PMID: 29570374 DOI: 10.2214/ajr.17.18367] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
258 Huang JY, Samarasena JB, Tsujino T, Chang KJ. EUS-guided portal pressure gradient measurement with a novel 25-gauge needle device versus standard transjugular approach: a comparison animal study. Gastrointest Endosc. 2016;84:358-362. [PMID: 26945557 DOI: 10.1016/j.gie.2016.02.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
259 Bonifazi F, Sica S, Angeletti A, Marktel S, Prete A, Iori AP, Olivari D, Rossetti G, Bertaina A, Botti S, Busca A, Carella AM, Cerretti R, Gargiulo G, Grassi A, Gualandi F, Irrera G, Milone G, Risitano AM, Santarone S, Vassallo E, Zecca M, Ciceri F, Pomponio G. Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group. Transplantation 2021;105:686-94. [PMID: 33273315 DOI: 10.1097/TP.0000000000003569] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Burroughs AK, Thalheimer U. Hepatic venous pressure gradient in 2010: optimal measurement is key. Hepatology. 2010;51:1894-1896. [PMID: 20512984 DOI: 10.1002/hep.23710] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
261 Giri S, Sundaram S. Decompensation in Patients With Advanced NAFLD: More Questions That Need Answering. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01180-0. [PMID: 34752963 DOI: 10.1016/j.cgh.2021.10.043] [Reference Citation Analysis]
262 Jalan R, De Chiara F, Balasubramaniyan V, Andreola F, Khetan V, Malago M, Pinzani M, Mookerjee RP, Rombouts K. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J Hepatol. 2016;64:823-833. [PMID: 26654994 DOI: 10.1016/j.jhep.2015.11.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
263 Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6-14. [PMID: 24757653 DOI: 10.3350/cmh.2014.20.1.6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
264 Grözinger G, Wiesinger B, Schmehl J, Kramer U, Mehra T, Grosse U, König C. Portosystemic pressure reduction achieved with TIPPS and impact of portosystemic collaterals for the prediction of the portosystemic-pressure gradient in cirrhotic patients. European Journal of Radiology 2013;82:2258-64. [DOI: 10.1016/j.ejrad.2013.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
265 Bosch J, Sauerbruch T. Esophageal varices: Stage-dependent treatment algorithm. Journal of Hepatology 2016;64:746-8. [DOI: 10.1016/j.jhep.2015.11.039] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
266 Pasarín M, Abraldes JG, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol 2017; 23(37): 6777-6787 [PMID: 29085222 DOI: 10.3748/wjg.v23.i37.6777] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
267 Zhang W, Peng C, Zhang S, Huang S, Shen S, Xu G, Zhang F, Xiao J, Zhang M, Zhuge Y, Wang L, Zou X, Lv Y. EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertension. Gastrointest Endosc 2021;93:565-72. [PMID: 32615178 DOI: 10.1016/j.gie.2020.06.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
268 Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, Turco L, Calvanese C, Simoni P, Guardigli M, Arena R, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014;59:643-650. [PMID: 24038116 DOI: 10.1002/hep.26700] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
269 Sourianarayanane A, Talluri J, Humar A, Mccullough AJ. Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis: . European Journal of Gastroenterology & Hepatology 2017;29:516-23. [DOI: 10.1097/meg.0000000000000825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
270 Procopet B, Bureau C, Métivier S, Selves J, Robic MA, Christol C, Grigorescu M, Vinel J, Péron J. Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients. European Journal of Gastroenterology & Hepatology 2012;24:1209-13. [DOI: 10.1097/meg.0b013e328355e2ba] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
271 Garcia-Tsao G. Can We Rely on Changes in HVPG in Patients with Cirrhosis? Hepatology 2021;74:2945-7. [PMID: 34569630 DOI: 10.1002/hep.32159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Chang Y, Suk KT, Jeong SW, Yoo JJ, Kim SG, Kim YS, Lee SH, Kim HS, Kang SH, Baik SK, Kim DJ, Kim MY, Jang JY. Application of Hepatic Venous Pressure Gradient to Predict Prognosis in Cirrhotic Patients with a Low Model for End-Stage Liver Disease Score. Diagnostics (Basel) 2020;10:E805. [PMID: 33050413 DOI: 10.3390/diagnostics10100805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Garcia-Tsao G, Abraldes JG. Nonselective Beta-Blockers in Compensated Cirrhosis: Preventing Variceal Hemorrhage or Preventing Decompensation? Gastroenterology 2021;161:770-3. [PMID: 33989660 DOI: 10.1053/j.gastro.2021.04.077] [Reference Citation Analysis]
274 Kim HY, Jin EH, Kim W, Lee JY, Woo H, Oh S, Seo JY, Oh HS, Chung KH, Jung YJ, Kim D, Kim BG, Lee KL. The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients. Medicine (Baltimore). 2015;94:e1031. [PMID: 26091449 DOI: 10.1097/md.0000000000001031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 3.1] [Reference Citation Analysis]
275 Mendoza YP, Rodrigues SG, Bosch J, Berzigotti A. Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis. Digestive and Liver Disease 2020;52:958-65. [DOI: 10.1016/j.dld.2020.06.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
276 Brunner F, Berzigotti A, Bosch J. Prevention and treatment of variceal haemorrhage in 2017. Liver Int. 2017;37 Suppl 1:104-115. [PMID: 28052623 DOI: 10.1111/liv.13277] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 7.4] [Reference Citation Analysis]
277 Golse N, Joly F, Combari P, Lewin M, Nicolas Q, Audebert C, Samuel D, Allard MA, Sa Cunha A, Castaing D, Cherqui D, Adam R, Vibert E, Vignon-Clementel IE. Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept. J Hepatol 2021;74:661-9. [PMID: 33212089 DOI: 10.1016/j.jhep.2020.10.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
278 Sánchez-cabús S, Fondevila C, Calatayud D, Ferrer J, Taurá P, Fuster J, García-valdecasas JC. Importance of the temporary portocaval shunt during adult living donor liver transplantation: Temporary Portocaval Shunt. Liver Transpl 2013;19:174-83. [DOI: 10.1002/lt.23558] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
279 Levick C, Phillips-Hughes J, Collier J, Banerjee R, Cobbold JF, Wang LM, Piechnik SK, Robson MD, Neubauer S, Barnes E, Pavlides M. Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study. PLoS One 2019;14:e0221066. [PMID: 31430314 DOI: 10.1371/journal.pone.0221066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
280 Bolognesi M, Di Pascoli M, Sacerdoti D. Clinical role of non-invasive assessment of portal hypertension. World J Gastroenterol 2017; 23(1): 1-10 [PMID: 28104976 DOI: 10.3748/wjg.v23.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
281 Boyer-Diaz Z, Morata P, Aristu-Zabalza P, Gibert-Ramos A, Bosch J, Gracia-Sancho J. Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical. Nutrients 2020;12:E2627. [PMID: 32872239 DOI: 10.3390/nu12092627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
282 Ronot M, Lambert S, Elkrief L, Doblas S, Rautou PE, Castera L, Vilgrain V, Sinkus R, Van Beers BE, Garteiser P. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol. 2014;24:1394-1402. [PMID: 24626745 DOI: 10.1007/s00330-014-3124-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
283 Mandorfer M, Hernández-Gea V, García-Pagán JC, Reiberger T. Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review. Semin Liver Dis 2020;40:240-55. [PMID: 32557480 DOI: 10.1055/s-0040-1708806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
284 Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
285 Podrug K, Trkulja V, Zelenika M, Bokun T, Madir A, Kanizaj TF, O'Beirne J, Grgurevic I. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography. Dig Dis Sci 2021. [PMID: 34739624 DOI: 10.1007/s10620-021-07277-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Baffy G, Bosch J. Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it? J Hepatol 2021:S0168-8278(21)02090-0. [PMID: 34606912 DOI: 10.1016/j.jhep.2021.09.029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Ooka Y, Suzuki E, Chiba T, Kato N, Komiyama Y, Takawa M, Nagamatsu H, Shiina S. Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient. Int J Med Sci 2019;16:1614-20. [PMID: 31839749 DOI: 10.7150/ijms.37040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
288 Huang JY, Samarasena JB, Tsujino T, Lee J, Hu KQ, McLaren CE, Chen WP, Chang KJ. EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc. 2017;85:996-1001. [PMID: 27693644 DOI: 10.1016/j.gie.2016.09.026] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
289 Veldhuijzen van Zanten D, Buganza E, Abraldes JG. The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis. Clin Liver Dis 2021;25:327-43. [PMID: 33838853 DOI: 10.1016/j.cld.2021.01.002] [Reference Citation Analysis]
290 Qi X, Zhou F, Lv H, Chen H, Xu W, Xing S, Wang F, Yang C. A novel noninvasive assessment of hepatic venous pressure gradient and portal pressure computed from computed tomography angiography. Arch Med Sci. 2014;10:1052-1054. [PMID: 25395960 DOI: 10.5114/aoms.2014.46224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
291 Abraldes JG, Bureau C, Stefanescu H, Augustin S, Ney M, Blasco H, Procopet B, Bosch J, Genesca J, Berzigotti A; for the Anticipate Investigators. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study: Hepatology, Vol. XX, No. X, 2016 Abraldes et al. Hepatology 2016;64:2173-84. [DOI: 10.1002/hep.28824] [Cited by in Crossref: 115] [Cited by in F6Publishing: 100] [Article Influence: 19.2] [Reference Citation Analysis]
292 Ma J, Gong X, Luo J, Gu J, Yan Z, Zhang W, Li C, Zhang Z, Yang M. Impact of Intrahepatic Venovenous Shunt on Hepatic Venous Pressure Gradient Measurement. J Vasc Interv Radiol 2020;31:2081-8. [PMID: 33261743 DOI: 10.1016/j.jvir.2020.08.027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
293 Xu MJ, Cai Y, Wang H, Altamirano J, Chang B, Bertola A, Odena G, Lu J, Tanaka N, Matsusue K. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology. 2015;149:1030-1041.e6. [PMID: 26099526 DOI: 10.1053/j.gastro.2015.06.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 11.7] [Reference Citation Analysis]
294 Liu Y, Tang T, Örmeci N, Huang Y, Wang J, Li X, Li Z, An W, Liu D, Zhang C, Liu C, Liu J, Liu C, Wang G, Mosconi C, Cappelli A, Bruno A, Akçalar S, Çelebioğlu E, Üstüner E, Bilgiç S, Ellik Z, Asiller ÖÖ, Li L, Zhang H, Kang N, Xu D, He R, Wang Y, Bu Y, Gu Y, Ju S, Golfieri R, Qi X. Noncontrast-enhanced MRI-based Noninvasive Score for Portal Hypertension (CHESS1802): An International Multicenter Study. J Clin Transl Hepatol 2021;9:818-27. [PMID: 34966645 DOI: 10.14218/JCTH.2021.00177] [Reference Citation Analysis]
295 Fang C, Lim A, Sidhu PS. Ultrasound-based liver elastography in the assessment of fibrosis. Clin Radiol 2020;75:822-31. [PMID: 32067699 DOI: 10.1016/j.crad.2020.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
296 Kitson MT, Roberts SK, Colman JC, Paul E, Button P, Kemp W. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scandinavian Journal of Gastroenterology 2015;50:462-9. [DOI: 10.3109/00365521.2014.964758] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
297 Wang J, Liu D, Qi X. A step forward to predict the risk of post-hepatectomy portal hypertension. Journal of Hepatology 2021;75:249-50. [DOI: 10.1016/j.jhep.2021.02.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis. Scand J Gastroenterol. 2013;48:487-495. [PMID: 22871085 DOI: 10.3109/00365521.2012.711848] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
299 Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012;56:696-703. [PMID: 21767510 DOI: 10.1016/j.jhep.2011.07.005] [Cited by in Crossref: 215] [Cited by in F6Publishing: 175] [Article Influence: 19.5] [Reference Citation Analysis]
300 Amat-Roldan I, Berzigotti A, Gilabert R, Bosch J. Assessment of hepatic vascular network connectivity with automated graph analysis of dynamic contrast-enhanced US to evaluate portal hypertension in patients with cirrhosis: A pilot study. Radiology. 2015;277:268-276. [PMID: 26020435 DOI: 10.1148/radiol.2015141941] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
301 Yamamoto A, Kawada N, Jogo A, Murai K, Kotani K, Kageyama K, Hamamoto S, Sohgawa E, Uchida-Kobayashi S, Enomoto M, Tamori A, Miki Y. Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein. Gut 2021;70:1199-201. [PMID: 32816966 DOI: 10.1136/gutjnl-2020-322367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
302 Degré D, Gustot T, Gerkens A, Boon N, Schreiber J, Lepida A, Sersté T, Deltenre P, Devière J, Trépo E, Moreno C. Insulin resistance is associated with esophageal varices in alcoholic liver disease patients: . European Journal of Gastroenterology & Hepatology 2016;28:792-6. [DOI: 10.1097/meg.0000000000000627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Lisotti A, Azzaroli F, Cucchetti A, Buonfiglioli F, Cecinato P, Calvanese C, Simoni P, Arena R, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension. Liver Int. 2016;36:1313-1321. [PMID: 26786880 DOI: 10.1111/liv.13070] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
304 Rössle M, Blanke P, Fritz B, Schultheiss M, Bettinger D. Free Hepatic Vein Pressure Is Not Useful to Calculate the Portal Pressure Gradient in Cirrhosis: A Morphologic and Hemodynamic Study. Journal of Vascular and Interventional Radiology 2016;27:1130-7. [DOI: 10.1016/j.jvir.2016.03.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
305 Elkrief L, Rautou PE, Ronot M, Lambert S, Dioguardi Burgio M, Francoz C, Plessier A, Durand F, Valla D, Lebrec D. Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology. 2015;275:589-598. [PMID: 25469784 DOI: 10.1148/radiol.14141210] [Cited by in Crossref: 126] [Cited by in F6Publishing: 104] [Article Influence: 15.8] [Reference Citation Analysis]
306 Dillon A, Galvin Z, Sultan AA, Harman D, Guha IN, Stewart S. Transient elastography can stratify patients with Child–Pugh A cirrhosis according to risk of early decompensation. European Journal of Gastroenterology & Hepatology 2018;30:1434-40. [DOI: 10.1097/meg.0000000000001224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
307 Zipprich A, Winkler M, Seufferlein T, Dollinger MM. Comparison of balloon vs. straight catheter for the measurement of portal hypertension. Aliment Pharmacol Ther. 2010;32:1351-1356. [PMID: 21050237 DOI: 10.1111/j.1365-2036.2010.04484.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
308 Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC; HALT-C Trial Group. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012;55:1019-1029. [PMID: 22030902 DOI: 10.1002/hep.24752] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
309 Zhao Y, Guo L, Huang Q, Zhang R, Sun X, Zhao L, Li C, Nie Y, Sun G, Liu J. Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient. Medicine (Baltimore) 2019;98:e17900. [PMID: 31764786 DOI: 10.1097/MD.0000000000017900] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
310 Kirby JM, Cho KJ, Midia M. Image-guided Intervention in Management of Complications of Portal Hypertension: More than TIPS for Success. RadioGraphics 2013;33:1473-96. [DOI: 10.1148/rg.335125166] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
311 Sánchez-cabús S, Abraldes JG, Taurá P, Calatayud D, Fondevila C, Fuster J, Ferrer J, García-pagán JC, García-valdecasas JC. Lack of Correlation Between Preoperative and Intraoperative Liver Hemodynamics: A Descriptive Analysis. Transplantation 2014;97:116-21. [DOI: 10.1097/tp.0b013e3182a8613d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
312 Vespasiani-Gentilucci U, Rombouts K. Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension. Gut 2015;64:523-4. [PMID: 24966286 DOI: 10.1136/gutjnl-2014-307583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
313 Hametner S, Ferlitsch A, Ferlitsch M, Etschmaier A, Schöfl R, Ziachehabi A, Maieron A. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test. PLoS One. 2016;11:e0149230. [PMID: 26895398 DOI: 10.1371/journal.pone.0149230] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
314 Procopet B, Cristea VM, Robic MA, Grigorescu M, Agachi PS, Metivier S, Peron JM, Selves J, Stefanescu H, Berzigotti A, Vinel JP, Bureau C. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. Dig Liver Dis. 2015;47:411-416. [PMID: 25732434 DOI: 10.1016/j.dld.2015.02.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
315 Tey TT, Gogna A, Irani FG, Too CW, Lo HG, Tan BS, Tay KH, Lui HF, Chang PE. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics. Singapore Med J 2016;57:132-7. [PMID: 26996384 DOI: 10.11622/smedj.2016054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
316 Jansen C, Möller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A, Schierwagen R, Praktiknjo M, Abdullah Z, Lehmann J, Thomas D, Strassburg CP, Latz E, Mueller S, Rössle M, Trebicka J. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology 2018;67:1472-84. [PMID: 29059466 DOI: 10.1002/hep.29612] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 11.5] [Reference Citation Analysis]
317 Mura VL, Nicolini A, Tosetti G, Primignani M. Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement. World J Hepatol 2015; 7(4): 688-695 [PMID: 25866605 DOI: 10.4254/wjh.v7.i4.688] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
318 Marasco G, Colecchia A, Dajti E, Ravaioli F, Cucchetti A, Cescon M, Festi D. Prediction of posthepatectomy liver failure: Role of SSM and LSPS. J Surg Oncol. 2019;119:400-401. [PMID: 30561034 DOI: 10.1002/jso.25345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
319 Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018;12:1-10. [PMID: 29064029 DOI: 10.1007/s12072-017-9827-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
320 Lin JY, Zhang CH, Zheng L, Li HJ, Zhu YM, Fan X, Li F, Xia Y, Huang MZ, Yang SH, Qi XL, Huo HZ, Chen HS, Lou XL, Luo M. Establishment and assessment of the hepatic venous pressure gradient using biofluid mechanics (HVPGBFM): protocol for a prospective, randomised, non-controlled, multicentre study. BMJ Open 2019;9:e028518. [PMID: 31796472 DOI: 10.1136/bmjopen-2018-028518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
321 Ble M, Procopet B, Miquel R, Hernandez-Gea V, García-Pagán JC. Transjugular liver biopsy. Clin Liver Dis. 2014;18:767-778. [PMID: 25438282 DOI: 10.1016/j.cld.2014.07.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
322 Payancé A, Silva‐junior G, Bissonnette J, Tanguy M, Pasquet B, Levi C, Roux O, Nekachtali O, Baiges A, Hernández‐gea V, Laouénan C, Lebrec D, Albuquerque M, Paradis V, Moreau R, Valla D, Durand F, Boulanger CM, Garcia‐pagan J, Rautou P. Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis. Hepatology 2018;68:1508-18. [DOI: 10.1002/hep.29903] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
323 Kibrit J, Khan R, Jung BH, Koppe S. Clinical Assessment and Management of Portal Hypertension. Semin Intervent Radiol 2018;35:153-9. [PMID: 30087517 DOI: 10.1055/s-0038-1660793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
324 Fang C, Sidhu PS. Ultrasound-based liver elastography: current results and future perspectives. Abdom Radiol (NY). 2020;45:3463-3472. [PMID: 32918106 DOI: 10.1007/s00261-020-02717-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
325 Maiwall R, Pasupuleti SSR, Jain P, Sarin SK. Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis. Hepatol Commun 2021;5:293-308. [PMID: 33553976 DOI: 10.1002/hep4.1607] [Reference Citation Analysis]
326 Are VS, Vuppalanchi R, Vilar-Gomez E, Chalasani N. Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis. Clin Gastroenterol Hepatol 2021;19:1292-1293.e3. [PMID: 32629127 DOI: 10.1016/j.cgh.2020.06.070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
327 Augustin S, González A, Badia L, Millán L, Gelabert A, Romero A, Segarra A, Martell M, Esteban R, Guardia J, Genescà J. Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding. Hepatology 2012;56:706-14. [DOI: 10.1002/hep.25686] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
328 Ferstl P, Trebicka J. Acute Decompensation and Acute-on-Chronic Liver Failure. Clin Liver Dis 2021;25:419-30. [PMID: 33838858 DOI: 10.1016/j.cld.2021.01.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
329 Azoulay D, Ramos E, Casellas-Robert M, Salloum C, Lladó L, Nadler R, Busquets J, Caula-Freixa C, Mils K, Lopez-Ben S, Figueras J, Lim C. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. JHEP Rep 2021;3:100190. [PMID: 33294830 DOI: 10.1016/j.jhepr.2020.100190] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Lipinski M, Saborowski M, Heidrich B, Attia D, Kasten P, Manns MP, Gebel M, Potthoff A. Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre. Scand J Gastroenterol. 2018;53:1107-1113. [PMID: 30270689 DOI: 10.1080/00365521.2018.1498913] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
331 Nakagawa A, Atsukawa M, Tsubota A, Kondo C, Okubo T, Arai T, Itokawa N, Narahara Y, Iwakiri K. Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients. World J Gastroenterol 2016; 22(21): 5104-5113 [PMID: 27275103 DOI: 10.3748/wjg.v22.i21.5104] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
332 Matteo J, Caci D, Soule E, Cunningham J, Hood P. Precision Onion Skinning Technique for Transjugular Intrahepatic Portosystemic Shunt Revision. Cureus 2018;10:e3180. [PMID: 30364717 DOI: 10.7759/cureus.3180] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
333 Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, Augustin S, Mookerjee RP, Michelena J, Smyrk TC, Buob D, Leteurtre E, Rincón D, Ruiz P, García-Pagán JC, Guerrero-Marquez C, Jones PD, Barritt AS 4th, Arroyo V, Bruguera M, Bañares R, Ginès P, Caballería J, Roskams T, Nevens F, Jalan R, Mathurin P, Shah VH, Bataller R. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014;146:1231-9.e1-6. [PMID: 24440674 DOI: 10.1053/j.gastro.2014.01.018] [Cited by in Crossref: 221] [Cited by in F6Publishing: 205] [Article Influence: 27.6] [Reference Citation Analysis]
334 Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6-14. [PMID: 24757653 DOI: 10.3350/cmh.2014. 20.1.6] [Reference Citation Analysis]
335 Rosselli M, MacNaughtan J, Jalan R, Pinzani M. Beyond scoring: a modern interpretation of disease progression in chronic liver disease. Gut 2013;62:1234-41. [PMID: 23645629 DOI: 10.1136/gutjnl-2012-302826] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
336 Téllez L, Rodríguez-Santiago E, Albillos A. Fontan-Associated Liver Disease: A Review. Ann Hepatol 2018;17:192-204. [PMID: 29469053 DOI: 10.5604/01.3001.0010.8634] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
337 Reverter E. Liver biopsy? Long life to the transjugular route. Dig Liver Dis 2019;51:1152-3. [PMID: 31054963 DOI: 10.1016/j.dld.2019.03.031] [Reference Citation Analysis]
338 Saab S, Kim NG, Lee EW. Practical Tips on TIPS: When and When Not to Request It. Am J Gastroenterol 2020;115:797-800. [PMID: 32427674 DOI: 10.14309/ajg.0000000000000611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Buechter M, Manka P, Theysohn JM, Reinboldt M, Canbay A, Kahraman A. Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis. 2018;50:54-60. [PMID: 29102174 DOI: 10.1016/j.dld.2017.09.138] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
340 Berzigotti A, Bosch J. Pharmacologic management of portal hypertension. Clin Liver Dis. 2014;18:303-317. [PMID: 24679496 DOI: 10.1016/j.cld.2013.12.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
341 Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Kundi M, Ferenci P, Gangl A, Trauner M. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol. 2011;9:602-608.e1. [PMID: 21397726 DOI: 10.1016/j.cgh.2011.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]